| Dec'17 | Dec'16 | Dec'15 | ||||
|---|---|---|---|---|---|---|
Cash flows used in operating activities | ||||||
Net loss | ||||||
-13,429 | -13,110 | -17,894 | ||||
Adjustments for: | ||||||
Depreciation | ||||||
1 | 3 | 6 | ||||
Stock-based compensation | ||||||
6,297 | 9,074 | 15,784 | ||||
Convertible note related accretion expense | ||||||
152 | 116 | 96 | ||||
Changes in non-cash operating balances: | ||||||
Accounts receivable and other receivables | ||||||
-77 | -2 | 52 | ||||
Research tax credit receivable | ||||||
0 | 271 | 344 | ||||
Security deposit | ||||||
0 | -7 | 0 | ||||
Prepaid expense | ||||||
0 | 0 | -1 | ||||
Inventories | ||||||
-13 | 35 | 51 | ||||
Accounts payable and accrued liabilities | ||||||
863 | -883 | 318 | ||||
Deferred revenue | ||||||
0 | 0 | -2,509 | ||||
Net cash flows used in operating activities | ||||||
-6,206 | -4,502 | -3,753 | ||||
Cash flows from financing activities | ||||||
Proceeds from issuance of share capital | ||||||
5,039 | 6,147 | 3,586 | ||||
Share issue costs | ||||||
0 | 0 | -48 | ||||
Payments under option settlement agreements | ||||||
0 | 0 | -43 | ||||
Net cash flows provided by financing activities | ||||||
5,039 | 6,147 | 3,495 | ||||
Cash flows used in investing activities | ||||||
Purchase of property and equipment | ||||||
0 | -2 | 0 | ||||
Net (decrease) increase in cash | ||||||
-1,167 | 1,643 | -258 | ||||
Income taxes paid | ||||||
0 | 0 | 0 | ||||
Interest paid | ||||||
0 | 0 | 0 | ||||
Shares and warrants issued on connection with convertible notes | ||||||
1,171 | 0 | 58 | ||||
Share issued in settlement of finance charge | ||||||
0 | 0 | 0 | ||||